Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department

ConditionFluid Therapy
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Monastir

About this trial

Intravascular volume expansion is a common intervention in critically ill patients with acute circulatory failure.we test the hypothesis that a mini-bolus fluid challenge, of either 50 ml , can predict fluid responsiveness in spontaneously breathing patients with hemodynamic instability.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with spontaneous breathing

urine output of below 0.5ml/kg per hour over 1 hour

tachycardia (heart rate of greater than 100 beats per minute)

mottled skin.

Disqualifiers

Cardiac arrest

Acute respiratory distress syndrome

Coma Glasgow Scale < 14

Age of less than 18 years

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mini bolus 50

    Combination product

    receiving a "mini-bolus A":50 ml of crystalloid solution, regularly infused over 30 seconds

  • passive leg rising test

    Diagnostic test

    Passive leg raising technique: Initially, the patient is placed semi-recumbent with the head of the bed at 45°. After recording baseline measurement, the head of the bed is lowered and the legs are elevated to 45° for 2 minutes

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: Mini Bolus 50Active comparator 1 intervention
Group B: PLROther 1 intervention

Trial outcomes

Primary outcomes

1

Measurement of the cardiac flow with the Estimate Continuous CO escco and SVescco (EsCCO) to predict the fluid responsiveness .

Predicting fluid responsiveness in spontaneously breathing patients with hemodynamic instability.

Time frame
at 3 minutes following fluid load in the day of admission

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.